KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines
Isabelle Messner, Giuseppe Cadeddu, Wolfgang Huckenbeck, Helen J. Knowles, Helmut E. Gabbert, Stephan E. Baldus, Karl-Ludwig SchaeferVolume:
139
Language:
english
DOI:
10.1007/s00432-012-1319-7
Date:
February, 2013
File:
PDF, 456 KB
english, 2013